AN ECONOMIC EVALUATION OF DASATINIB (SPRYCEL®) IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN CENTRAL AND EASTERN EUROPE

被引：1
|
作者：
Nagy, B. [1 ]
Kutikova, L. [2 ]
Stastny, M. [2 ]
Vasile, K. [3 ]
Nagy, Zsolnai, I [5 ]
Mayer, J. [4 ]
机构：
[1] Healthware Consulting Ltd, Budapest, Hungary
[2] Bristol Myers Squibb Co, Prague, Czech Republic
[3] Bristol Myers Squibb Co, Bucharest, Romania
[4] Univ Hosp Brno, Brno, Czech Republic
[5] Bristol Myers Squibb Co, Budapest, Hungary
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)66231-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A358 / A358
页数：1
相关论文
共 50 条
  • [41] Efficacy and Safety of Generic Imatinib in Chronic Phase of Chronic Myeloid Leukemia (CP-CML): Experience from a Multi-Center in China
    Zhou, Li
    Liu, Bingcheng
    Hu, Jianda
    Qu, Jianhua
    Hou, Ming
    Sun, Hui
    Jin, Jie
    Shen, Zhixiang
    BLOOD, 2019, 134
  • [42] Predictors of Ponatinib Therapy Duration Among Real-World Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients in the US
    Mauro, Michael J.
    McGarry, Lisa J.
    Lustgarten, Stephanie
    Huang, Hui
    BLOOD, 2016, 128 (22)
  • [43] Warning As Defiened By European Leukemia Net 2013 (ELN 2013) In Chronic Phase Chronic Myeloid Leukemia (CP-CML) Corresponds To Warning In The Clinical Practice?
    Fogliatto, Laura
    Capra, Marcelo
    Shaan, Mariza
    Costa, Tito Vanelli
    Breunig, Raquel
    Fraga, Christina G. S.
    Torriani, Mayde Seadi
    Silla, Lucia
    Daudt, Liane Esteves
    Fernandes, Mario Sergio
    Almeida, Denise
    Schilling, Marco Antonio
    Hellwig, Tania
    Fassina, Katia
    Wisintainer, Sabrina
    Moschen, Mariangela
    Daltoe, Tiago
    Zardo, Adriana
    Kratochvil, Juliana
    Fernandes, Viviane Magagnin
    Eickhoff, Cheila
    Nene, Moema
    Ahmad, Saozan
    Almeida, Andreia Dias
    Lenz, Vitor
    BLOOD, 2013, 122 (21)
  • [44] Use of dasatinib in patients (pts) with previously untreated chronic myelogenous leukemia (CML) in chronic phase (CML-CP)
    Atallah, E. L.
    Kantarjian, H.
    O'Brien, S.
    Jones, D.
    Borthakur, G.
    Nicaise, C.
    Cortes, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] SIX-YEAR FOLLOW-UP OF PATIENTS WITH IMATINIB-RESISTANT OR IMATINIB-INTOLERANT CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) RECEIVING DASATINIB
    Rea, D.
    Vellenga, E.
    Junghanss, C.
    Baccarani, M.
    Kantarjian, H.
    Lofgren, C.
    Dejardin, D.
    Hochhaus, A.
    HAEMATOLOGICA, 2012, 97 : 80 - 80
  • [46] TRANSPLANTS FOR CHRONIC MYELOID-LEUKEMIA (CML) IN CHRONIC PHASE (CP) - THE EFFECT OF AGE
    PETERSEN, FB
    CLIFT, RA
    BUCKNER, CD
    EXPERIMENTAL HEMATOLOGY, 1991, 19 (06) : 543 - 543
  • [47] Study of tumor cells immunophenotype in chronic phase (CP) of chronic myeloid leukemia (CML).
    Logacheva, NP
    Turkina, AG
    Shishkin, YV
    Zabotina, TN
    Baryshnikov, AY
    LEUKEMIA, 2001, 15 (03) : 504 - 504
  • [48] Evaluating the Role of Lower Dose Dasatinib in Newly Diagnosed Early Chronic Phase-Chronic Myeloid Leukemia (CML-CP)
    Naqvi, Kiran
    Cortes, Jorge E.
    Skinner, Jeffrey
    Jabbour, Elias J.
    Pemmaraju, Naveen
    Bose, Prithviraj
    Thompson, Philip A.
    Borthakur, Gautam
    Estrov, Zeev
    Kantarjian, Hagop M.
    BLOOD, 2017, 130
  • [49] Long-Term Follow-up of a Phase 1 Study of Ponatinib in Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML)
    Talpaz, Moshe
    Cortes, Jorge E.
    Kantarjian, Hagop
    Shah, Neil P.
    Bixby, Dale
    Flinn, Ian
    O'Hare, Thomas
    Hu, Simin
    Rivera, Victor M.
    Clackson, Tim
    Turner, Christopher D.
    Haluska, Frank G.
    Druker, Brian J.
    Deininger, Michael W.
    Mauro, Michael J.
    BLOOD, 2014, 124 (21)
  • [50] Achieving Early Landmark Response Is Predictive of Outcomes in Heavily Pretreated Patients with Chronic Phase Chronic Myeloid Leukemia (CP-CML) Treated with Ponatinib
    Mueller, Martin C.
    Baccarani, Michele
    Deininger, Michael W.
    Guilhot, Francois
    Hochhaus, Andreas
    Hughes, Timothy P.
    Shah, Neil P.
    Talpaz, Moshe
    Lustgarten, Stephanie
    Rivera, Victor M.
    Clackson, Tim
    Haluska, Frank G.
    Cortes, Jorge E.
    BLOOD, 2014, 124 (21)
12345